Literature DB >> 15197173

Screening of alternative models for transitional B cell maturation.

Gitit Shahaf1, David Allman, Michael P Cancro, Ramit Mehr.   

Abstract

Several functional and phenotypic B cell populations have been described in the spleen. These include the 'transitional' subsets, which are thought to be late differentiation intermediates of marrow-derived, mature follicular B cells. The exact progenitor-successor relationships of these transitional subsets, as well as whether a proliferative step is requisite for follicular B cell maturation, remain controversial. Moreover, whether late B cell differentiation might involve branched or asynchronous maturation pathways, thus allowing some cells to 'skip' one or more of these stages, has not been investigated. Herein we have used mathematical modeling to interrogate these possibilities. Using mathematical models that numerically simulate splenic B cell population dynamics, we have determined which alternative models of differentiation best fit existing in vivo labeling data. Our results indicate that follicular differentiation does not involve a proliferating splenic intermediate. Our results further suggest that some developing cells move directly from the immature marrow pool to more advanced semi-mature peripheral subsets without passing through the least mature subset in the spleen.

Mesh:

Year:  2004        PMID: 15197173     DOI: 10.1093/intimm/dxh109

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Lyn deficiency affects B-cell maturation as well as survival.

Authors:  Gitit Shahaf; Andrew J Gross; Michal Sternberg-Simon; Deborah Kaplan; Anthony L DeFranco; Ramit Mehr
Journal:  Eur J Immunol       Date:  2011-12-14       Impact factor: 5.532

2.  In old BALB/c mice, bone marrow pre-B cell and surrogate light chain reduction is associated with increased B cell reactivity to phosphorylcholine, but reduced T15 idiotype dominance.

Authors:  Kelly Khomtchouk; Sarah Alter; Michelle Ratliff; Bonnie B Blomberg; Richard L Riley
Journal:  Mech Ageing Dev       Date:  2016-11-19       Impact factor: 5.432

3.  A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival.

Authors:  Robert B Henderson; Katarzyna Grys; Anne Vehlow; Carine de Bettignies; Agnieszka Zachacz; Tom Henley; Martin Turner; Facundo Batista; Victor L J Tybulewicz
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

4.  Kinetic modeling reveals a common death niche for newly formed and mature B cells.

Authors:  Gitit Shahaf; Michael P Cancro; Ramit Mehr
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

5.  The in vitro derivation of phenotypically mature and diverse B cells from immature spleen and bone marrow precursors.

Authors:  Kirstin M Roundy; Amanda C Jacobson; Janis J Weis; John H Weis
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

6.  Reversing B cell aging.

Authors:  Ramit Mehr; Doron Melamed
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

Review 7.  From Discrete to Continuous Modeling of Lymphocyte Development and Plasticity in Chronic Diseases.

Authors:  Jennifer Enciso; Rosana Pelayo; Carlos Villarreal
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

Review 8.  Immunoinformatics: current trends and future directions.

Authors:  Joo Chuan Tong; Ee Chee Ren
Journal:  Drug Discov Today       Date:  2009-04-18       Impact factor: 7.851

9.  Understanding natural killer cell regulation by mathematical approaches.

Authors:  Carsten Watzl; Michal Sternberg-Simon; Doris Urlaub; Ramit Mehr
Journal:  Front Immunol       Date:  2012-12-12       Impact factor: 7.561

10.  B Cell Development in the Bone Marrow Is Regulated by Homeostatic Feedback Exerted by Mature B Cells.

Authors:  Gitit Shahaf; Simona Zisman-Rozen; David Benhamou; Doron Melamed; Ramit Mehr
Journal:  Front Immunol       Date:  2016-03-22       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.